ArticleCurrent oncology (Toronto, Ont.)2025
First Report of Pembrolizumab Activity in KIT-Mutated Thymic Carcinoma.
Tommaso Martino De Pas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleCurrent oncology (Toronto, Ont.)2025
Tommaso Martino De Pas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.